A few events in the life of the Group in 2005   ABL Luxembourg Activities: diagnostic interpretation and therapeutic choice using medical databases in the field of AIDS. Head office: Luxembourg and Liège, through its subsidiary ITS Intervention of the S.R.I.W. Group in 2005: participation in a capital increase alongside organisations such as EUREFI in order to finance the growth of activities, in collaboration with PEPITE in Liège. ACAPELA GROUP Activities: development and marketing of speech recognition software. Head office: Mons Intervention of the S.R.I.W. Group in 2005: participation in a capital increase in order to finance the developments of the company. ADNIN Activities: development of therapeutic systems for neural stimulation. Head office: Louvain-la-Neuve Intervention of the Group S.R.I.W. in 2005: participation in the capital during the creation of the company alongside SOPARTEC and VIVES. ASEPTIC TECHNOLOGIES Activities: research, development and production of equipment and tools used for filling operations in an aseptic environment for pharmacy. Head office: Gembloux Intervention of the S.R.I.W. Group in 2005: participation in a growth of capital alongside GSKB. BIENCA Activities: Production and marketing of an anti-infection enzymatic system for the agri-food sector. Head office: Seneffe Intervention of the Group S.R.I.W. in 2005: participation in a growth of capital in order to finance the expected growth of activities, alongside companies such as ING Belgium. CARDIO3 Activities: cellular therapy, regeneration of cardiac muscle by cellular transplantation in patients suffering from heart failure. Head office: Braine l'Alleud Intervention of the Group S.R.I.W. in 2005: participation in an increase of capital of the company alongside the business angels, CARDIOVASCULAIRE ONDERZOEK Aalst and ANTEROGEN (South Korea). CITYNEO Activities: design, development and marketing of geo-localized information services for mobile telephony and Internet. Head office: Paris Intervention of the S.R.I.W. Group in 2005: participation in the reinforcement of the company through the conversion in capital of an advance to consolidate the commercial development of the company. DIMACO Activities: optical control of industrial packaging. Head office: Gembloux Intervention of the S.R.I.W. Group in 2005: underwriting to a bonded debt with DEXIA. ECOLAM Activities: study, design and production of beams and structures made of glued-laminated timber. Head office: Achêne Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital to assure the company the financial means needed to pursue its development. H-PHAR Activities: development of medication for inhibiting the reproduction of the AIDS virus. Head office: Gosselies Intervention of the S.R.I.W. Group in 2005: participation in an increase of capital to finish Phase I of the development. KITOZYME Activities: exploitation of an enzymatic technology of production of chitosan. Head office: Herstal Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital by warrants. INTERNATIONAL BRACHYTHERAPY (en abrégé IBt) Activities: Research, development, production and marketing of implants for treating different kinds of cancers. Head office: Seneffe Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital by warrants. MEDSYS Invest Activities: Research, development, production and marketing of devices for laparoscopy for gynaecology, urology and abdominal surgery. Head office: Gembloux Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital with VIVES in order to finance the growth of activities. MULTISCOPE PALACE Activities: Exploitation of cinema complexes under the brand name IMAGIX (Mons-Tournai). Head office: Zulte Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital and underwriting of a bonded debt to finance investments (mainly a new complex in Tournai).   ONCOMETHYLOME SCIENCES Activities: Research, development in the field of biotechnology, including the methylation of genes for the precocious diagnostic of cancer. Head office: Liège Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital with ROTHSCHILD FRANCE, ING PRIVATE EQUITY, POLYTECHNOS, LIFE SCIENCE PARTNERS AND MEUSINVEST in order to finance the growth of activities. ROSSEL PRINTING COMPANY Activities: body printing company of the ROSSEL press group. Head office: Nivelles Intervention of the S.R.I.W. Group in 2005: underwriting of a bonded debt to finance the new printing company. TECSEN Activities: the treatment of surfaces using a metallization procedure of plastics. Head office: Jumet Intervention of the S.R.I.W. Group in 2005: underwriting of a bonded debt. TIGENIX Activities: functional repair of damaged and sick musculoskeletal tissues by therapy, based on source cells. Head office: Leuven Intervention of the S.R.I.W. Group in 2005: participation in an increase in capital with ING PRIVATE EQUITY, AURIGA VENTURES, CAPRICORN, HSS VENTURES (USA), FORTIS (through FAGUS), etc.